Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma
Study Number: 

NCG 235413

Phase: 
II
Trial categories: 
Neuroblastoma
Pediatric Cancers
Principal Investigator: